Geode Capital Management’s Harpoon Therapeutics, Inc. Common Stock HARP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-149,262
| Closed | -$1.7M | – | 4729 |
|
|
2023
Q4 | $1.7M | Buy |
149,262
+124,349
| +499% | +$977K | ﹤0.01% | 3164 |
|
|
2023
Q3 | $100K | Buy |
24,913
+3,270
| +15% | +$24.2K | ﹤0.01% | 4252 |
|
|
2023
Q2 | $154K | Hold |
21,643
| – | – | ﹤0.01% | 4164 |
|
|
2023
Q1 | $161K | Hold |
21,643
| – | – | ﹤0.01% | 4149 |
|
|
2022
Q4 | $157K | Sell |
21,643
-1,230
| -5% | -$10.4K | ﹤0.01% | 4216 |
|
|
2022
Q3 | $221K | Hold |
22,873
| – | – | ﹤0.01% | 4154 |
|
|
2022
Q2 | $436K | Sell |
22,873
-16,846
| -42% | -$436K | ﹤0.01% | 3838 |
|
|
2022
Q1 | $1.97M | Sell |
39,719
-2,038
| -5% | -$106K | ﹤0.01% | 3267 |
|
|
2021
Q4 | $3.15M | Buy |
41,757
+3,736
| +10% | +$255K | ﹤0.01% | 3144 |
|
|
2021
Q3 | $3M | Buy |
38,021
+2,825
| +8% | +$284K | ﹤0.01% | 3180 |
|
|
2021
Q2 | $4.88M | Buy |
35,196
+5,669
| +19% | +$1.08M | ﹤0.01% | 2926 |
|
|
2021
Q1 | $6.18M | Buy |
29,527
+11,233
| +61% | +$2.25M | ﹤0.01% | 2678 |
|
|
2020
Q4 | $3.04M | Buy |
18,294
+2,638
| +17% | +$408K | ﹤0.01% | 2859 |
|
|
2020
Q3 | $2.66M | Buy |
15,656
+2,588
| +20% | +$373K | ﹤0.01% | 2728 |
|
|
2020
Q2 | $2.17M | Buy |
13,068
+3,115
| +31% | +$486K | ﹤0.01% | 2795 |
|
|
2020
Q1 | $1.15M | Buy |
9,953
+1,210
| +14% | +$170K | ﹤0.01% | 2955 |
|
|
2019
Q4 | $1.29M | Buy |
8,743
+4,680
| +115% | +$710K | ﹤0.01% | 3176 |
|
|
2019
Q3 | $554K | Buy |
4,063
+548
| +16% | +$77K | ﹤0.01% | 3441 |
|
|
2019
Q2 | $457K | Buy |
3,515
+2,344
| +200% | +$272K | ﹤0.01% | 3498 |
|
|
2019
Q1 | $110K | Buy |
+1,171
| New | +$154K | ﹤0.01% | 3880 |
|
Geode Capital Management's HARP Position: Q1 2024 in Review
Geode Capital Management sold out of Harpoon Therapeutics, Inc. Common Stock (HARP) in Q1 2024, closing a stake of 149,262 shares — an estimated $1.7M sold.
Geode Capital Management first reported a position in HARP in Q1 2019 and held it in 20 quarters. The position peaked at $6.18M in Q1 2021. 0 funds tracked by Wall St. Rank hold HARP as of Q1 2024.
- Geode Capital Management reported no remaining Harpoon Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
- Geode Capital Management sold 149,262 Harpoon Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $1.7M.
- Geode Capital Management first reported a position in Harpoon Therapeutics, Inc. Common Stock in Q1 2019 and held it in 20 quarters.
- Geode Capital Management's Harpoon Therapeutics, Inc. Common Stock position peaked at $6.18M in Q1 2021.
- 0 funds tracked by Wall St. Rank held Harpoon Therapeutics, Inc. Common Stock as of Q1 2024.
Based on Geode Capital Management's 13F filing for Q1 2024, filed 13 May 2024.